Prescription Drugs
  • This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes
    Metabolism
  • This drug is administered as an adjunct to diet and exercise to improve the glucose control of patients with type 2 diabetes. - Monotherapy - Combined therapy
  • Essential hypertension in which blood pressure is not properly controlled with irbesartan monotherapy
  • maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD
  • Short-term treatment of insomnia in adults
    Neurology/Psychiatry
  • Long-term treatment of patients aged 12 years and older with a confirmed diagnosis of Fabry disease (α-galactosidase A deficiency) who have an amenable mutation.
  • Mircera is an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia associated with chronic kidney disease (CKD in adult patients on dialysis and patients not on dialysis
  • 1) The treatment of adults with newly diagnosed, therapy-related acute myeloid leukemia (t-AML) 2) The treatment of adults with newly diagnosed AML with myelodysplasia-related changes (AML-MRC)
  • Co-administration with heparin in the patients who are: - target patients in the treatment of acute coronary syndrome (ACS) - patients with percutaneous transluminal coronary angioplasty (PTCA) or atherectomy
    Cardiovascular
맨위로